纳米颗粒作为非病毒载体的进步,可以有效地传递CRISPR/Cas9
Minse Kim1,2, Youngwoo Hwang2,3, Seongyu Lim1,2
1Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.
Pharmaceutics
|September 28, 2024
概括
非病毒纳米粒子为提供CRISPR/Cas9基因编辑技术提供了有希望的替代方案,克服了潜在临床应用和基因治疗的病毒载体的局限性.
科学领域:
- 生物技术和基因编辑
- 纳米医学和药物输送
背景情况:
- 聚类正规间隔短平行体重复 (CRISPR) /Cas9系统是一个革命性的基因编辑工具.
- 传统的CRISPR/Cas9传递病毒载体面临着局限性,引发了对替代方法的兴趣.
- 非病毒传递系统,特别是纳米粒子,正在成为可行的替代品.
研究的目的:
- 审查和评估用于CRISPR/Cas9传递的各种基于纳米粒子的非病毒载体的效率.
- 讨论这些纳米粒子系统的优势,局限性和挑战.
- 为CRISPR/Cas9在临床和基因疗法环境中提供非病毒传递方面的进展提供全面概述.
主要方法:
- 对CRISPR/Cas9交付的各种纳米粒子类型的文献综述和分析.
- 将纳米粒子分类为基于脂质的,基于聚合物的,基于无机的和基于细胞外囊泡的系统.
- 评估每个系统的效率,优势和局限性.
主要成果:
- 各种纳米粒子系统显示出有效的CRISPR/Cas9交付的潜力.
- 基于脂质,聚合物,无机和细胞外囊泡的纳米颗粒具有不同的好处和缺点.
- 在优化非病毒性传递策略方面取得了重大进展.
结论:
- 非病毒纳米粒子输送系统对于推进CRISPR/Cas9技术至关重要.
- 解决当前的挑战是实现CRISPR/Cas9基因疗法的全部临床潜力的关键.
- 对纳米粒子优化的持续研究将加速治疗应用.
相关概念视频
CRISPR
49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K


